Aprépitant — Général Nom IUPAC 5 ([(2R,3S) 2 ((R) 1 [3,5 bis(trifluoromethyl)phenyl]ethoxy) 3 (4 fluorophenyl)morpholino]methyl) 1H 1,2,4 triazol 3(2H) one … Wikipédia en Français
Aprepitant — drugbox IUPAC name = 5 [(2 S ,3 R ) 2 [(1 R ) 1 [3,5 bis(trifluoromethyl)phenyl] ethoxy] 3 (4 fluorophenyl)morpholin 4 yl] methyl] 1,2 dihydro 1,2,4 triazol 3 one CAS number = 170729 80 3 ATC prefix = A04 ATC suffix = AD12 ATC supplemental =… … Wikipedia
Aprepitant — Strukturformel Allgemeines Freiname Aprepitant Andere Namen … Deutsch Wikipedia
aprepitant — noun An antagonist]] drug]], 5 (2S,3R) 2 [(1R) 1 [3,5 bis(trifluoromethyl)phenyl] ethoxy] 3 (4 fluorophenyl)morpholin 4 yl] methyl] 1,2 dihydro 1,2,4 triazol 3 one, used to prevent nausea]] following chemotherapy]] … Wiktionary
aprepitant — aprep·i·tant (ə prepґĭ tənt) an antagonist of substance P, used as an antiemetic; administered orally … Medical dictionary
170729-80-3 — Aprépitant Aprépitant Général Nom IUPAC 5 ([(2R,3S) 2 ((R) 1 [3,5 bis(trifluoromethyl)phenyl]ethoxy) 3 (4 fluorophenyl)morpholino]methyl) 1H 1,2,4 triazol 3(2H) one … Wikipédia en Français
NK1 receptor antagonist — Neurokinin 1 (NK1) antagonists are a novel class of medications that possesses unique antidepressant,[1] anxiolytic,[2] and antiemetic properties. The discovery of neurokinin 1 (NK1) receptor antagonists was a turning point in the prevention of… … Wikipedia
Chemotherapy-induced nausea and vomiting — (CINV) is a common side effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving… … Wikipedia
Merck & Co. — Merck Co., Inc. (Merck Sharp Dohme (MSD) outside the United States and Canada) Type Public Traded as NYSE: … Wikipedia
Tachykinin receptor 1 — Rendering based on PDB 2KS9 … Wikipedia